AzTrials
AzTrials

Immature TeethNCT06631885

Efficacy of Integrated Nano-technology in Revascularization of Immature Necrotic Teeth

A study testing regenerative endodontic procedure using blood clot according to AAE and regenerative endodontic procedure using photo activated nanochitosan 2% in people with Immature Teeth and Necrotic Pulp, run by Minia University.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This trial aims to study the effect of photoactivated disinfection using Diod laser (810 nm) to activate photosensitive nanoparticle chitosan as an endodontic irrigant versus sodium hypochlorite followed by saline and then EDTA 17% on 1) postoperative pain and 2) the success of revascularization in patients with… Read more about this study

Who is it for?
Any age
Conditions the study is for
Immature Teeth, Necrotic Pulp
What is being tested?
regenerative endodontic procedure using blood clot according to AAE and regenerative endodontic procedure using photo activated nanochitosan 2%
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
No sites listed yet
Study dates
11 Oct 2024to 11 Apr 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • o Immature necrotic maxillary incisor with open apex greater than 1 mm.
  • Teeth where pulp space are not needed for post and core.
  • A restorable tooth.
  • Patients should be free from any systemic disease that may affect normal healing and predictable outcome.
  • Patients who will agree to the consent and will commit to follow-up period.

Who cannot join

  • o Non-restorable teeth.
  • Teeth with root fractures, internal or external root resorption.
  • Teeth with mature fully developed root with closed apex
  • Patients with any systemic disease that may affect predictable outcome

Trial locations and contacts

No sites are listed yet.

Mohamed Abdelmawla, assisstant lecturer contact

+20-1005757045

dr.mohammed.abdelmawla@gmail.com

About this study

Official title: Efficacy of Integrated Nano-technology in the Irrigation Protocol of Revascularization Technique In Immature Necrotic Teeth (Randomized Clinical Trial)

This trial aims to study the effect of photoactivated disinfection using Diod laser (810 nm) to activate photosensitive nanoparticle chitosan as an endodontic irrigant versus sodium hypochlorite followed by saline and then EDTA 17% on 1) postoperative pain and 2) the success of revascularization in patients with necrotic immature maxillary anterior teeth using a randomized clinical trial design.

Read the detailed description

randomized clinical trial will be conducted to investigate and compare the efficacy of photosensitized nano-chitosan 2% as an endodontic disinfectant during revascularization versus sodium hypochlorite, followed by EDTA 17% according to the standardized protocol of the American Association of endodontics.

Twenty individuals with necrotic, immature permanent anterior teeth will be recruited. They will be randomly assigned into two groups according to the received intervention: control group and test group.

pain will be evaluated as a primary outcome at 24 hours and one week post-intervention using numerical rating scale (NRS). In addition, the root development in terms of change in root length and apical foramen diameter and periapical bone healing will be evaluated as secondary outcomes using cone beam tomography.

Being tested
regenerative endodontic procedure using blood clot according to AAE, regenerative endodontic procedure using photo activated nanochitosan 2%
Keywords
regenerative endodontic procedure
Medical subject headings
Dental Pulp Necrosis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • regenerative endodontic procedure using blood clot according to AAEProcedure or surgery

    regenerative endodontic procedure using blood clot to replace the necrotic pulp tissues in immature teeth with a pulp like to tissue to complete root development. using AAE protocol

  • regenerative endodontic procedure using photo activated nanochitosan 2%Procedure or surgery

    regenerative endodontic procedure using blood clot to replace the necrotic pulp tissues in immature teeth with a pulp like to tissue to complete root development. using photosensitized nanochitosan for root canal disinfection

Study groups in NCT06631885
Study groupRoleWhat they receive
control group: using AAE protocolActive comparatorrevascularization using blood clot according to the standardized protocol of the American association of endodontics
Receives: Procedure: regenerative endodontic procedure using blood clot according to AAE
test groupExperimentaldiode laser will be used to activate photosensitized nano chitosan 2% for canal disinfection instead of NaOCl in the first visit of revascularization protocol
Receives: Procedure: regenerative endodontic procedure using photo activated nanochitosan 2%

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. pain intensity assessed by numerical rating scale

    postoperative pain using numerical rating scale

    Measured: 24 hours and 1 week after completion of the procedure

Secondary outcomes (3)
  1. root development

    change of root length

    Measured: 6 months, 1 year postoperative

  2. Apical foramen closure

    change in apical foramen diameter

    Measured: 6 months, 1 year postoperative

  3. periapical bone healing

    change in the area of periapical lesion

    Measured: 6 months, 1 year postoperative

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Oct 2024
  2. Study start11 Oct 2024 (estimated)
  3. Primary completion11 Nov 2024 (estimated)
  4. Study completion11 Apr 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
20 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06631885
Sponsor's protocol ID
(586/2022)
Status last verified
Oct 2024
First submitted
13 Sep 2024
Last updated
8 Oct 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing regenerative endodontic procedure using blood clot according to AAE and regenerative endodontic procedure using photo activated nanochitosan 2% in people with Immature Teeth and Necrotic Pulp, run by Minia University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 8 Oct 2024. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Mohamed Abdelmawla, assisstant lecturer (+20-1005757045, dr.mohammed.abdelmawla@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

pain intensity assessed by numerical rating scale (time frame: 24 hours and 1 week after completion of the procedure). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Oct 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in